PETS vs ZTEK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PETS exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by catastrophic fundamental decay. The company is experiencing a severe collapse in profitability with an ROE of -100.61% and accelerating revenue declines (-21.7% YoY, -29.95% Q/Q). Despite a very low Debt/Equity ratio, the current ratio of 0.89 indicates immediate liquidity risks, while a 0/4 earnings beat record over the last year suggests a complete loss of operational control.
ZTEK exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While the company shows strong top-line revenue growth of 73.10%, this is completely offset by a catastrophic operating margin of -4155.24% and a Price/Sales ratio of 54.78, suggesting extreme overvaluation. The stock is in a persistent bearish trend with a 58.3% decline over the last year and a lack of any meaningful profitability metrics. Overall, the company appears to be a speculative venture with unsustainable operational costs.
Compare Another Pair
Related Comparisons
PETS vs ZTEK: Head-to-Head Comparison
This page compares PetMed Express, Inc. (PETS) and Zentek Ltd. (ZTEK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.